COST-EFFECTIVENESS OF THE PNEUMOCOCCAL CONJUGATE VACCINE 10 VERSUS 13 ON PNEUMOCOCCAL DISEASE IN CHILDREN IN SWEDEN

被引：0
|
作者：
Peeters, E. [1 ]
Marijam, A. [2 ]
Chevalier, P. [1 ]
Ene, J. [3 ]
Folkesson, J. [3 ]
Izurieta, P. [2 ]
Joost, S. [4 ]
Urbonas, G. [5 ]
Adbelghany, M. [6 ]
机构：
[1] IQVIA, Zaventem, Belgium
[2] GSK, Wavre, Belgium
[3] IQVIA, Solna, Sweden
[4] GSK, Amersfoort, UT, Netherlands
[5] GSK, Warsaw, Poland
[6] GSK, Cairo, Egypt
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE166
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF 13-VALENT VERSUS 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE USE IN THE CZECH NATIONAL IMMUNIZATION PROGRAM
    Tichopad, A.
    Vitova, V.
    Roberts, C. S.
    Hajek, P.
    VALUE IN HEALTH, 2013, 16 (07) : A352 - A353
  • [32] COST-EFFECTIVENESS OF 13-VALENT VERSUS 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE USE IN CROATIA NATIONAL VACCINATION PROGRAM
    Tichopad, A.
    Pecen, L.
    Roberts, C. S.
    Uglesic, L.
    Tesovic, G.
    Rogier, K.
    VALUE IN HEALTH, 2014, 17 (07) : A608 - A608
  • [33] Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10-or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria
    Pugh, Sarah J.
    Fletcher, Mark A.
    Charos, Apostolos
    Imekraz, Lynda
    Wasserman, Matt
    Farkouh, Raymond
    INFECTIOUS DISEASES AND THERAPY, 2019, 8 (01) : 63 - 74
  • [34] Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children
    Shiragami M.
    Mizukami A.
    Leeuwenkamp O.
    Mrkvan T.
    Delgleize E.
    Kurono Y.
    Iwata S.
    Infectious Diseases and Therapy, 2015, 4 (1) : 93 - 112
  • [35] Cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in older Australians
    Dirmesropian, S.
    Wood, J. G.
    MacIntyre, C. R.
    Beutels, P.
    McIntyre, P.
    Menzies, R.
    Reyes, J. F.
    Chen, C.
    Newall, A. T.
    VACCINE, 2017, 35 (34) : 4307 - 4314
  • [36] A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries
    Martí S.G.
    Colantonio L.
    Bardach A.
    Galante J.
    Lopez A.
    Caporale J.
    Knerer G.
    Gomez J.A.
    Augustovski F.
    Pichon-Riviere A.
    Cost Effectiveness and Resource Allocation, 11 (1)
  • [37] A COST-EFFECTIVENESS ANALYSIS OF A 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CHILDREN IN SIX LATIN AMERICAN COUNTRIES
    Garcia Marti, S.
    Colantonio, L.
    Bardach, A.
    Lopez, A.
    Caporale, J.
    Augustovski, F.
    Riviere, Pichon A.
    Knerer, G.
    Gomez, J. A.
    VALUE IN HEALTH, 2011, 14 (07) : A538 - A538
  • [38] Cost-Effectiveness Comparison of Pneumococcal Conjugate Vaccines in Turkish Children
    Marijam, Alen
    Olbrecht, Jan
    Ozakay, Alev
    Eken, Volkan
    Meszaros, Kinga
    VALUE IN HEALTH REGIONAL ISSUES, 2019, 19 : 34 - 44
  • [39] Cost-effectiveness of pneumococcal vaccine - Reply
    Lieu, T
    Ray, GT
    Black, S
    Shinefield, H
    Butler, J
    Miller, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (04): : 440 - 441
  • [40] Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
    Tomczyk, Sara
    Lessa, Fernanda C.
    Sanchez, Jacqueline
    Pena, Chabela
    Fernandez, Josefina
    Carvalho, M. Gloria
    Pimenta, Fabiana
    Cedano, Doraliza
    Whitney, Cynthia G.
    Verani, Jennifer R.
    Coradin, Hilma
    Garib, Zacarias
    De Oliveira, Lucia Helena
    Feris-Iglesias, Jesus
    BMC INFECTIOUS DISEASES, 2018, 18
12345